Mortality, Credibility Data Assumptions Loom Large in NAIC's PBR Work

September 30, 2011 at 09:10 AM
Share & Print

Insurance regulators are wrestling over mortality guidelines and data credibility as part of the exposure draft for principles-based reporting system for life insurance products.

The subgroup of the Life Actuarial Task Force, created by the National Association of Insurance Commissioners to study the impact of principles-based reserving (PBR) on the life insurance industry, asked the American Academy of Actuaries to clarify the section they essentially wrote on mortality assumptions, especially the use of the terms "credibility segment" and "mortality segment."

On a teleconference call Sept. 29 as part of the cancelled Summer meeting lineup, the New York Insurance Department's Amanda Fenwick argued for her approach to simplification, and garnered a lot of feedback on her approach, which did not sound so simple, and which some worried could results in higher reserves for life insurance companies.

At issue is the size of the data available for companies and whether it is statistically credible. If it is deemed to not be statistically credible, the concern is the company would have to use industry data and higher margins, which would then mean higher reserves for companies. This could happen, some argue, if smaller groups' experience is looked at separately (i.e., the result will be less "credible" than if looked at in its entirety).

The PBR undertaking is a long process, already on its sixth year, of coming up with a model for a new way of reserving, from a prescriptions-based standard that is some 125 years old to a new principles-based system that takes into account modern life insurance products and ways of doing business.

A task force member, Kansas Insurance Department actuary Mark Birdsall, spoke toward the end of the discussion about whether regulators should require margins on each type of assumption and allow some adjustment in those margins, or if they should put an aggregate margin on the final reserve amount to adjust for all the tinkering of mortality data. Some in the industry support this approach, but most are awaiting the results of the impact study undertaken at NAIC's behest on the PBR draft as it stood nine months ago.

Towers WatsonThe study is being done by Towers Watson & Company, New York (NYSE:TW). Phase II data is due Oct. 14th, and preliminary results are expected to be delivered at the NAIC Fall Meeting later this month outside of Washington, D.C. The full report is expected to come out later this year, if not at the NAIC meeting itself. Some advocated waiting and seeing what the impact study said before deliberating too much more.

Earlier, life insurers were having trouble giving the consulting firm the figures it needed to complete a study of the possible impact of shifting to a PBR system for life products.

In the study, Towers Watson consultants are supposed to examine the effects of VM-20, a section of a draft valuation manual that deals with PBR issues.  

Future discussions will include Birdsall's noting of prposed methodologies that would allow a more level playing field for all companies, which he says is far preferable than the one that distorts the margins.

"One of the pieces of feedback from the PBR impact study, when we put margins on each assumption, (we found) it is time consuming and mostly guesswork if the companies aren't going to be doing it the same way," Birdsall said. "There are a range of reserve results for products that are essentially the same because of all this guesswork going into it," he said. This can lead to distortion of mortality results, he added.

Birdsall recommended that regulators "dial in" the level of statutory conservatism that they think is appropriate. There is concern that some companies are prone to being very aggressive in their assumptions of mortality rates, so Birdsall recommended using an aggregate on top of that to reduce or limit aggressive mortality assumptions by some companies, so "companies don't push the envelope too hard" and so regulators do not unintentionally give aggressive companies an advantage.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Resource Center